Adenosine transport by plasma membrane monoamine transporter: Reinvestigation and comparison with organic cations

Drug Metabolism and Disposition

Volumn 38, Issue 10, 2010, Pages 1798-1805

  Zhou, Mingyan ^a,b   Duan, Haichuan ^a   Engel, Karen ^a,c   Xia, Li ^a,d   Wang, Joanne ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

^c BAYER PHARMA AG   (Germany)

^d CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; ADENOSINE; CATION; DILAZEP; DIPYRIDAMOLE; NITROBENZYLTHIOINOSINE; NUCLEIC ACID BASE; NUCLEOSIDE; NUCLEOSIDE TRANSPORTER; NUCLEOSIDE TRANSPORTER INHIBITOR; PLASMA MEMBRANE MONOAMINE TRANSPORTER; PROTEIN INHIBITOR; SEROTONIN; UNCLASSIFIED DRUG;

ACIDITY; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL PH; CONTROLLED STUDY; DRUG DISPOSITION; DRUG METABOLISM; DRUG TRANSPORT; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; HETEROLOGOUS EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MEMBRANE POTENTIAL; NONHUMAN; OOCYTE; PH; PRIORITY JOURNAL; PROTEIN TRANSPORT; XENOPUS LAEVIS;

1-METHYL-4-PHENYLPYRIDINIUM; ADENOSINE; ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUILIBRATIVE NUCLEOSIDE TRANSPORT PROTEINS; FEMALE; HYDROGEN-ION CONCENTRATION; MEMBRANE POTENTIALS; OOCYTES; ORGANIC CATION TRANSPORT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN; SUBSTRATE SPECIFICITY; TRANSFECTION; XENOPUS LAEVIS;

EID: 77957122215     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.110.032987     Document Type: Article

References (32)

1. Baldwin SA, Beal PR, Yao SY, King AE, Cass CE, and Young JD (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch 447:735-743.
2. Baldwin SA, Yao SY, Hyde RJ, Ng AM, Foppolo S, Barnes K, Ritzel MW, Cass CE, and Young JD (2005) Functional characterization of novel human and mouse equilibrative nucleoside transporters (hENT3 and mENT3) located in intracellular membranes. J Biol Chem 280:15880-15887. (Pubitemid 40616710)
3. Ballarín M, Fredholm BB, Ambrosio S, and Mahy N (1991) Extracellular levels of adenosine and its metabolites in the striatum of awake rats: inhibition of uptake and metabolism. Acta Physiol Scand 142:97-103.
4. Barnes K, Dobrzynski H, Foppolo S, Beal PR, Ismat F, Scullion ER, Sun L, Tellez J, Ritzel MW, Claycomb WC, et al. (2006) Distribution and functional characterization of equilibrative nucleoside transporter-4, a novel cardiac adenosine transporter activated at acidic pH. Circ Res 99:510-519.
5. Dahlin A, Xia L, Kong W, Hevner R, and Wang J (2007) Expression and immunolocalization of the plasma membrane monoamine transporter (PMAT) in the brain. Neuroscience 146:1192-1211.
6. Eltzschig HK, Abdulla P, Hoffman E, Hamilton KE, Daniels D, Schönfeld C, Löffler M, Reyes G, Duszenko M, Karhausen J, et al. (2005) HIF-1-dependent repression of equilibrative nucleoside transporter (ENT) in hypoxia. J Exp Med 202:1493-1505.
7. Engel K and Wang J (2005) Interaction of organic cations with a newly identified plasma membrane monoamine transporter. Mol Pharmacol 68:1397-1407. (Pubitemid 41539995)
8. Engel K, Zhou M, and Wang J (2004) Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem 279:50042-50049.
9. Fink T, Lund P, Pilgaard L, Rasmussen JG, Duroux M, and Zachar V (2008) Instability of standard PCR reference genes in adipose-derived stem cells during propagation, differentiation and hypoxic exposure. BMC Mol Biol 9:98.
10. Fujita T, Urban TJ, Leabman MK, Fujita K, and Giacomini KM (2006) Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci 95:25-36.
11. Govindarajan R, Leung GP, Zhou M, Tse CM, Wang J, and Unadkat JD (2009) Facilitated mitochondrial import of antiviral and anticancer nucleoside drugs by human equilibrative nucleoside transporter-3. Am J Physiol Gastrointest Liver Physiol 296:G910-G922.
12. Gray JH, Owen RP, and Giacomini KM (2004) The concentrative nucleoside transporter family, SLC28. Pflugers Arch 447:728-734.
13. Griffith DA and Jarvis SM (1996) Nucleoside and nucleobase transport systems of mammalian cells. Biochim Biophys Acta 1286:153-181.
14. Hammond JR, Stolk M, Archer RG, and McConnell K (2004) Pharmacological analysis and molecular cloning of the canine equilibrative nucleoside transporter 1. Eur J Pharmacol 491:9-19. (Pubitemid 38501770)
15. Hellsten Y, Maclean D, Rådegran G, Saltin B, and Bangsbo J (1998) Adenosine concentrations in the interstitium of resting and contracting human skeletal muscle. Circulation 98:6-8.
16. Koepsell H, Lips K, and Volk C (2007) Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res 24:1227-1251. (Pubitemid 46876495)
17. Kong W, Engel K, and Wang J (2004) Mammalian nucleoside transporters. Curr Drug Metab 5:63-84.
18. Latini S and Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463-484. (Pubitemid 33029920)
19. MacLean DA, Sinoway LI, and Leuenberger U (1998) Systemic hypoxia elevates skeletal muscle interstitial adenosine levels in humans. Circulation 98:1990-1992.
20. Olah ME and Stiles GL (1992) Adenosine receptors. Annu Rev Physiol 54:211-225.
21. Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P, and Caciagli F (1999) Trophic effects of purines in neurons and glial cells. Prog Neurobiol 59:663-690. (Pubitemid 29457587)
22. Romanowski T, Sikorska K, and Bielawski KP (2008) GUS and PMM1 as suitable reference genes for gene expression analysis in the liver tissue of patients with chronic hepatitis. Med Sci Monit 14:BR147-152.
23. Sebastiao AM and Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 471-534.
24. Visser F, Vickers MF, Ng AM, Baldwin SA, Young JD, and Cass CE (2002) Mutation of residue 33 of human equilibrative nucleoside transporters 1 and 2 alters sensitivity to inhibition of transport by dilazep and dipyridamole. J Biol Chem 277:395-401. (Pubitemid 34952071)
25. Ward JL, Sherali A, Mo ZP, and Tse CM (2000) Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells. Ent2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine. J Biol Chem 275:8375-8381. (Pubitemid 30180179)
26. Wright SH and Dantzler WH (2004) Molecular and cellular physiology of renal organic cation and anion transport. Physiol Rev 84:987-1049. (Pubitemid 38823772)
27. Xia L, Engel K, Zhou M, and Wang J (2007) Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Renal Physiol 292:F682-F690. (Pubitemid 46220537)
28. Young JD, Yao SY, Sun L, Cass CE, and Baldwin SA (2008) Human equilibrative nucleoside transporter (ENT) family of nucleoside and nucleobase transporter proteins. Xenobiotica 38:995-1021.
29. Zetterström T, Vernet L, Ungerstedt U, Tossman U, Jonzon B, and Fredholm BB (1982) Purine levels in the intact rat brain. Studies with an implanted perfused hollow fibre. Neurosci Lett 29:111-115.
30. Zhou M, Engel K, and Wang J (2007a) Evidence for significant contribution of a newly identified monoamine transporter (PMAT) to serotonin uptake in the human brain. Biochem Pharmacol 73:147-154. (Pubitemid 44853932)
31. Zhou M, Xia L, Engel K, and Wang J (2007b) Molecular determinants of substrate selectivity of a novel organic cation transporter (PMAT) in the SLC29 family. J Biol Chem 282:3188-3195. (Pubitemid 47084340)
32. Zhou M, Xia L, and Wang J (2007c) Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos 35:1956-1962. (Pubitemid 47481592)